Company Description
Pulmonx Corporation, a commercial-stage medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases.
The company offers Zephyr Endobronchial Valve, a solution for the treatment of patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a balloon catheter and console system with flow and pressure sensors that are used to assess the presence of collateral ventilation.
It also offers StratX Lung Analysis Platform, a cloud-based quantitative computed tomography analysis service that offers information on emphysema destruction, fissure completeness, and lobar volume to help identify target lobes for the treatment with Zephyr Valves.
The company serves emphysema patients in the United States, Europe, the Middle East, Africa, the Asia-Pacific, and internationally.
The company was formerly known as Pulmonx and changed its name to Pulmonx Corporation in December 2013.
Pulmonx Corporation was incorporated in 1995 and is headquartered in Redwood City, California.
| Country | United States |
| IPO Date | Oct 1, 2020 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 279 |
| CEO | Steven S. Williamson |
Contact Details
Address: 700 Chesapeake Drive Redwood City, California 94063 United States | |
| Phone | 650-364-0400 |
| Website | pulmonx.com |
Stock Details
| Ticker Symbol | LUNG |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| IPO Price | $19.00 |
| CIK Code | 0001127537 |
| CUSIP Number | 745848101 |
| ISIN Number | US7458481014 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| David A. Lehman | General Counsel and Secretary |
| Geoffrey Beran Rose | Chief Commercial Officer |
| Steven S. Williamson | Chief Executive Officer, President and Director |
| Mehul Joshi | Chief Financial Officer |
| Sri Radhakrishnan | Chief Technical Officer |
| Marcee M. Maroney | Vice President of Marketing |
| Sarah Huber | Vice President of Sales (U.S.) |
| Lisa Paul | Chief People Officer |
| Jérôme Erath | Senior Vice President and GM of Europe Middle-East & Africa |
| John B. McKune | Vice President and Corporate Controller |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Apr 5, 2024 | ARS | Filing |
| Apr 5, 2024 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Apr 5, 2024 | DEF 14A | Other definitive proxy statements |
| Apr 2, 2024 | 8-K | Current Report |
| Mar 22, 2024 | 144 | Filing |
| Mar 15, 2024 | S-8 | Securities to be offered to employees in employee benefit plans |
| Mar 11, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
| Feb 29, 2024 | SC 13G | Statement of acquisition of beneficial ownership by individuals |
| Feb 27, 2024 | 10-K | Annual Report |
| Feb 22, 2024 | 144 | Filing |